On May 2, 2022, the ITC issued a Notice of Investigation in Certain Botulinum Toxin Products and Process for Manufacturing or Relating to Same (Inv. No. 337-TA-1313).
On April 29, 2022, Precision Holdings USA Inc. of Rocklin, California and Innovamed Health LLC of San Antonio, Texas (collectively, “Complainants”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337.
On April 28, 2022, the ITC issued a Notice of Investigation in Certain Mobile Electronic Devices (Inv. No. 337-TA-1312).
On April 28, 2022, ALJ David P. Shaw issued the public version of his April 1, 2022 final initial determination (“ID”) finding no violation of Section 337 in Certain UMTS and LTE Cellular Communication Modules and Components Thereof (Inv. No. 337-TA-1240).
On April 28, 2022, Bell Semiconductor, LLC of Bethlehem, Pennsylvania (“Bell Semic”) filed a complaint requesting that the ITC commence an investigation pursuant to section 337.
Oblon.com
Protecting Designs Blog
Life Sciences Blog